
Sku: WE2618

Catalog No.: WE2661
Specification: 1mg/5mg/25mg/50mg/100mg
Stock: In stock
Product details, specifications, documents, and related products are available from the catalog record. Learn more
Background:Telisotuzumab is a monoclonal antibody that targets the c-Met receptor, which plays a crucial role in the growth and metastasis of certain tumor cells. c-Met is the receptor for hepatocyte growth factor (HGF), and its overexpression or mutation is associated with the development of various cancers, including non-small cell lung cancer (NSCLC), pancreatic cancer, and renal cell carcinoma.
ucallm
Datasheet, COA, SDS, and protocol files can be requested from technical support.
Emailinfo@mail.ucallm.com
Phone+(1)-866-986-9598
WeChat / IMUcallm-Tech
HoursMonday-Friday 09:00-18:00 CST